Cargando…
Polygenic Risk Score: Clinically Useful Tool for Prediction of Cardiovascular Disease and Benefit from Lipid-Lowering Therapy?
Improvement in risk prediction of atherosclerotic cardiovascular disease (ASCVD) using information on the genetic predisposition at an individual level might offer new possibilities for the successful management of such complex trait. Latest developments in genetic research with the conduction of ge...
Autores principales: | Arnold, Natalie, Koenig, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481165/ https://www.ncbi.nlm.nih.gov/pubmed/33156471 http://dx.doi.org/10.1007/s10557-020-07105-7 |
Ejemplares similares
-
2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy
por: Banach, Maciej, et al.
Publicado: (2022) -
Validity of polygenic risk scores: are we measuring what we think we are?
por: Janssens, A Cecile J W
Publicado: (2019) -
Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses
por: Sun, Luanluan, et al.
Publicado: (2021) -
Polygenic Risk Score Prediction for Endometriosis
por: Kloeve-Mogensen, Kirstine, et al.
Publicado: (2021) -
Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region
por: Tada, Hayato, et al.
Publicado: (2021)